Speaker
Ruby Mehta, MD
Food and Drug Adminstration
Biography
Currently, I am the Acting Associate Director for Therapeutics Review (ADTR) in Division of Hepatology and Nutrition (DHN), in the office of new drugs (OND), Center for drug research and evaluation (CDER) at the FDA. Prior to this position, I was the lead physician in DHN. By training I am a pediatric gastroenterologist and hepatologist. DHN reviews applications submitted for all hepatology drug development, except oncology, antiviral drugs, gene therapy, or large molecule biologics (such as probiotics). DHN also works across organization and DHN is consulted by all centers at the FDA, where hepatology expertise is required.